https://orcid.org/0000-0003-4895-9707
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Michael E. Wechsler & John J. Oppenheimer. (2023) Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review. Journal of Asthma 60:9, pages 1633-1645.
Read now
Read now
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Vito De Novellis, Paola Rogliani & Maria Gabriella Matera. (2022) Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings. Expert Review of Respiratory Medicine 16:11-12, pages 1205-1212.
Read now
Read now
Mario Cazzola, Paola Rogliani, Silvio Naviglio, Luigino Calzetta & Maria Gabriella Matera. (2022) An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert Opinion on Pharmacotherapy 23:10, pages 1205-1216.
Read now
Read now
Edward Kerwin, Paul Dorinsky, Mehul Patel, Kimberly Rossman, Colin Reisner, Andrea Maes, Patrick Darken, Dianne Griffis & Harald Fjällbrant. (2022) A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment. Journal of Asthma 59:7, pages 1420-1432.
Read now
Read now
Josuel Ora, Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera & Paola Rogliani. (2021) Current long-acting muscarinic antagonists for the treatment of asthma. Expert Opinion on Pharmacotherapy 22:17, pages 2343-2357.
Read now
Read now
Timothy E. Albertson, Janelle V. Pugashetti, Florence Chau-Etchepare, James A. Chenoweth & Susan Murin. (2020) Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 21:16, pages 1991-2010.
Read now
Read now
Maria Gabriella Matera, Carmela Belardo, Michele Rinaldi, Barbara Rinaldi & Mario Cazzola. (2020) New perspectives on the role of muscarinic antagonists in asthma therapy. Expert Review of Respiratory Medicine 14:8, pages 817-824.
Read now
Read now
Articles from other publishers (11)
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2023) Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?. Drugs 83:11, pages 957-965.
Crossref
Crossref
Thomas B. Casale, Michael B. Foggs & Ronald C. Balkissoon. (2022) Optimizing asthma management: Role of long-acting muscarinic antagonists. Journal of Allergy and Clinical Immunology 150:3, pages 557-568.
Crossref
Crossref
Mario Cazzola, Fulvio Braido, Luigino Calzetta, Maria Gabriella Matera, Alessio Piraino, Paola Rogliani & Nicola Scichilone. (2022) The 5T approach in asthma: Triple Therapy Targeting Treatable Traits. Respiratory Medicine 200, pages 106915.
Crossref
Crossref
Alberto Papi, Konstantinos Kostikas, Ivan Nikolaev & Ioannis Kottakis. (2022) Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A
Combination Therapy for Asthma. Current Respiratory Medicine Reviews 18:2, pages 77-85.
Crossref
Crossref
Paola ROGLIANI, Beatrice L. RITONDO, Francesco CAVALLI, Federica M. GIORGINO, Andrea GIROLAMI, Gloria PANE, Gabriella PEZZUTO, Bartolomeo ZERILLO, Ermanno PUXEDDU & Josuel ORA. (2022) Synergy across the drugs approved for the treatment of asthma. Minerva Medica 113:1.
Crossref
Crossref
Mario Cazzola & Maria Gabriella Matera. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
712
728
.
Jutta Beier, Henrik Watz, Zuzana Diamant, Jens M. Hohlfeld, Dave Singh, Pascale Pinot, Ieuan Jones & Hanns-Christian Tillmann. (2021) Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial. ERJ Open Research 7:2, pages 00425-2020.
Crossref
Crossref
Hannah A. Blair. (2021) Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma. Drugs 81:6, pages 709-719.
Crossref
Crossref
Alberto Papi, Leonardo M Fabbri, Huib A.M. Kerstjens, Paola Rogliani, Henrik Watz & Dave Singh. (2021) Inhaled long-acting muscarinic antagonists in asthma – A narrative review. European Journal of Internal Medicine 85, pages 14-22.
Crossref
Crossref
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2020) Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and Asthma. US Respiratory & Pulmonary Diseases 5:1, pages 18.
Crossref
Crossref
M. G. Matera, C. P. Page, L. Calzetta, P. Rogliani & M. Cazzola. (2019) Pharmacology and Therapeutics of Bronchodilators Revisited. Pharmacological Reviews 72:1, pages 218-252.
Crossref
Crossref